ArticleDrug design, development and therapy2013

Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E2 inhibitory properties.

Carmen Limban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.